SMARCB1 mutations are not a common cause of multiple meningiomas

被引:38
作者
Hadfield, K. D. [1 ]
Smith, M. J. [1 ]
Trump, D. [1 ]
Newman, W. G. [1 ]
Evans, D. G. [1 ]
机构
[1] Univ Manchester, St Marys Hosp, MAHSC, Dept Med Genet, Manchester M13 9WL, Lancs, England
关键词
MOLECULAR-GENETIC-ANALYSIS; NF2; GENE; HSNF5/INI1;
D O I
10.1136/jmg.2009.075721
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Schwannomas and meningiomas are both part of the tumour spectrum of neurofibromatosis type 2 (NF2) and are associated with somatic loss of chromosome 22. They are also found commonly within the general population, unrelated to NF2. Germline SMARCB1 mutations have recently been identified as a pathogenic cause of a subset of familial schwannomatosis cases, and SMARCB1 is a candidate gene for causation of both schwannomas and meningiomas. Recently, Bacci et al reported a germline SMARCB1 mutation associated with familial schwannomatosis and multiple meningiomas. They concluded that SMARCB1 mutations can predispose to multiple meningiomas. Methods We screened the SMARCB1 gene in a panel of 47 patients with multiple meningioma unrelated to NF2. Results We found no germline mutations. Conclusion We conclude that while meningiomas may be associated with the schwannomatosis phenotype, SMARCB1 is not a major contributor to multiple meningioma disease.
引用
收藏
页码:567 / 568
页数:2
相关论文
共 14 条
  • [1] Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
    Abaza, MM
    Makariou, E
    Armstrong, M
    Lalwani, AK
    [J]. LARYNGOSCOPE, 1996, 106 (06) : 694 - 699
  • [2] BACCI C, 2009, NEUROGENETICS
  • [3] Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis
    Boyd, C.
    Smith, M. J.
    Kluwe, L.
    Balogh, A.
    MacCollin, M.
    Plotkin, S. R.
    [J]. CLINICAL GENETICS, 2008, 74 (04) : 358 - 366
  • [4] DUMANSKI JP, 1990, CANCER RES, V50, P5863
  • [5] Multiple meningiomas:: differential involvement of the NF2 gene in children and adults
    Evans, DGR
    Watson, C
    King, A
    Wallace, AJ
    Baser, ME
    [J]. JOURNAL OF MEDICAL GENETICS, 2005, 42 (01) : 45 - 48
  • [6] Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification
    Evans, Gareth R.
    Ramsden, R. T.
    Shenton, A.
    Gokhale, C.
    Bowers, N. L.
    Huson, S. M.
    Pichert, G.
    Wallace, A.
    [J]. JOURNAL OF MEDICAL GENETICS, 2007, 44 (07) : 424 - 428
  • [7] Grand F, 1999, CANCER RES, V59, P3870
  • [8] Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
    Hadfield, K. D.
    Newman, W. G.
    Bowers, N. L.
    Wallace, A.
    Bolger, C.
    Colley, A.
    McCann, E.
    Trump, D.
    Prescott, T.
    Evans, D. G. R.
    [J]. JOURNAL OF MEDICAL GENETICS, 2008, 45 (06) : 332 - 339
  • [9] Germline mutation of INI1/SMARCB1 in familial schwannomatosis
    Hulsebos, Theo J. M.
    Plomp, Astrid S.
    Wolterman, Ruud A.
    Robanus-Maandag, Els C.
    Baas, Frank
    Wesseling, Pieter
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (04) : 805 - 810
  • [10] Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas
    Mohyuddin, A
    Neary, WJ
    Wallace, A
    Wu, CL
    Purcell, S
    Reid, H
    Ramsden, RT
    Read, A
    Black, G
    Evans, DGR
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) : 315 - 322